Literature DB >> 10485665

From the Food and Drug Administration.

J E Henney.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10485665

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Thiazolidinediones and bone.

Authors:  Alberto Falchetti; Laura Masi; Maria Luisa Brandia
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

2.  Generic antiepileptic drugs: current controversies and future directions.

Authors:  Michael D Privitera
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

3.  Pioglitazone-induced acute rhabdomyolysis.

Authors:  Raoudha Slim; Chaker Ben Salem; Michele Zamy; Michele Zami; Michel Biour
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 19.112

4.  Bone is a target for the antidiabetic compound rosiglitazone.

Authors:  S O Rzonca; L J Suva; D Gaddy; D C Montague; B Lecka-Czernik
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

5.  Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma.

Authors:  M A Rumi; H Sato; S Ishihara; K Kawashima; S Hamamoto; H Kazumori; T Okuyama; R Fukuda; N Nagasue; Y Kinoshita
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.